Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation
RR Robles-Rivera… - Oxidative medicine …, 2020 - Wiley Online Library
Diabetes mellitus (DM) is a progressive disease induced by a sustained state of chronic
hyperglycemia that can lead to several complications targeting highly metabolic cells …
hyperglycemia that can lead to several complications targeting highly metabolic cells …
Diabetic macular edema
F Bandello, R Lattanzio, I Zucchiatti, A Arrigo… - … A step-by-step Guide for …, 2019 - Springer
Diabetic macular edema (DME) is the most common cause of visual deterioration in patients
affected by diabetes mellitus. Grid and focal laser photocoagulation, according to the …
affected by diabetes mellitus. Grid and focal laser photocoagulation, according to the …
Diabetic retinopathy: emerging concepts of current and potential therapy
MZ Sadikan, NA Abdul Nasir - Naunyn-Schmiedeberg's Archives of …, 2023 - Springer
Diabetic retinopathy (DR) is one of the leading causes of permanent central blindness
worldwide. Despite the complexity and inadequate understanding of DR pathogenesis …
worldwide. Despite the complexity and inadequate understanding of DR pathogenesis …
[HTML][HTML] Ginsenoside Rb1 attenuates diabetic retinopathy in streptozotocin-induced diabetic rats
C Dong, P Liu, H Wang, M Dong, G Li, Y Li - Acta Cirúrgica Brasileira, 2019 - SciELO Brasil
Purpose: To investigated the effects of ginsenoside Rb1 on diabetic retinopathy in
streptozotocin-induced diabetic rats. Methods: Diabetes was induced by a single …
streptozotocin-induced diabetic rats. Methods: Diabetes was induced by a single …
Topical treatment of diabetic retinopathy: A systematic review
MS Thagaard, AS Vergmann… - Acta …, 2022 - Wiley Online Library
Diabetic retinopathy (DR) is the most common microvascular complication in diabetes and
may cause severe visual impairment. Until late stages of DR, treatment options are limited …
may cause severe visual impairment. Until late stages of DR, treatment options are limited …
[HTML][HTML] Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial
A Ramezani, H Molazem, M Entezari… - Journal of Ophthalmic …, 2024 - ncbi.nlm.nih.gov
Purpose To evaluate the short-term additive effects of topical ketorolac to intravitreal
bevacizumab (IVB) in the management of center-involved diabetic macular edema (CI …
bevacizumab (IVB) in the management of center-involved diabetic macular edema (CI …
[HTML][HTML] Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome
H Guclu, VP Gurlu - International Journal of Ophthalmology, 2019 - ncbi.nlm.nih.gov
AIM To compare safety and efficacy of intravitreal dexamethasone (IVD) implant with topical
nepafenac (TN) 0.1% in previously untreated Irvine-Gass syndrome (IGS) in clinical practice …
nepafenac (TN) 0.1% in previously untreated Irvine-Gass syndrome (IGS) in clinical practice …
Diyabetik Maküla Ödeminde İntravitreal Bevasizumab ve Topikal Nepafenak Kombinasyon Tedavisinin İntravitreal Bevasizumab ile Karşılaştırılması.
R BİRGÜL, H DALDAL… - MN Opthalmology/MN …, 2024 - search.ebscohost.com
Öz Amaç: Diyabetik maküla ödemi (DMÖ) patofizyolojisinde başta vasküler endotelyal
büyüme faktörü (VEGF) ve prostoglandinler (PG) olmak üzere çeşitli medyatörler rol oynar …
büyüme faktörü (VEGF) ve prostoglandinler (PG) olmak üzere çeşitli medyatörler rol oynar …
[PDF][PDF] Evaluation of choroidal changes in patients with ocular toxoplasmosis using spectral domain optical coherence tomography
M Murat, FM Turkcu, A Sahin, C Akpolat - Age (years, y), 2018 - researchgate.net
We aimed to examine the choroidal changes in ocular toxoplasmosis with spectral domain
optical coherence tomography using the enhanced depth-imaging mode. The clinical and …
optical coherence tomography using the enhanced depth-imaging mode. The clinical and …